VOLUNTARY ANNOUNCEMENT ENTERING INTO THE VACCINE SUPPLY AGREEMENTVaccine Supply Agreement • April 21st, 2021
This announcement is made by the board of directors (the “Board”) of Clover Biopharmaceuticals, Ltd. (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to update the shareholders of the Company and potential investors on the latest business development of the Group.
